Automated high-throughput sorting of living cells using laser light and AI

Tests on living cell cultures are becoming increasingly important for personalized medicine, drug development and clinical research. The Aachen-based Fraunhofer Institutes for Laser Technology ILT and for Production Technology IPT have developed an AI-assisted high-throughput process that now makes it possible to automatically isolate specific cell types. Using a so-called LIFTOSCOPE, laboratories can localize, identify and analyze dozens of living cells per second in order to transfer them to microtiter plates with laser-induced forward transfer (LIFT).

„German researchers have developed a high-speed process that uses AI and laser technology for sorting living cells. This game-changing method, crucial for personalized medicine and drug development, automatically isolates specific cell types at remarkable speeds. The innovative tool called LIFTOSCOPE allows labs to analyze and transfer dozens of cells per second using laser-induced forward transfer method.“

Originamitteilung:

Tests on living cell cultures are becoming increasingly important for personalized medicine, drug development and clinical research. The Aachen-based Fraunhofer Institutes for Laser Technology ILT and for Production Technology IPT have developed an AI-assisted high-throughput process that now makes it possible to automatically isolate specific cell types. Using a so-called LIFTOSCOPE, laboratories can localize, identify and analyze dozens of living cells per second in order to transfer them to microtiter plates with laser-induced forward transfer (LIFT).

share this recipe:
Facebook
Twitter
Pinterest

Weitere spannende Artikel

ERC Consolidator Grant für Georg Winter gibt rasant wachsendem Forschungsfeld weiteren Auftrieb

Maßgeschneiderte kleine Moleküle, die sich an Krebs verursachende Proteine heften und Tumorzellen dadurch unschädlich machen – das ist Georg Winters Spezialgebiet, in dem sich der Forschungsgruppenleiter am CeMM der ÖAW als weltweit führender Experten etabliert hat. Sein neuestes ERC CoG Projekt GENEomorph hebt seine Forschung auf eine neue Ebene: Anstatt Krebsproteine wie bisher für die zelluläre Müllabfuhr zu markieren, nimmt Winter mit seinen Design-Molekülen nun sogenannte Transkriptionsfaktoren ins Visier, ein vielversprechender Weg für neue Medikamente. Das sieht auch der Europäische Forschungsrat ERC so: Er fördert dieses Projekt in den nächsten fünf Jahren mit 1,9 Millionen Euro.

Read More